Biotech 2050 Podcast cover image

Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics

Biotech 2050 Podcast

CHAPTER

Advancements and Opportunities in Ophthalmology

Discussion on the changes and exciting advancements in ophthalmology, including recent FDA approvals of complement inhibitor therapies for geographic atrophy in age-related macular degeneration.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner